Nachrichten zur McKesson Corp Aktie

McKessons agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.…

McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately…

Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Global Teleradiology Market Report by Technology Imaging Techniques End Users…

McKessons (MCK) shares rally on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top…

MCK earnings call for the period ending June 30, 2024.…

McKessons (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to…

Paris (www.aktiencheck.de) - McKesson: Sprungbrett Seitwärtskonsolidierung - Chartanalyse Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet sich in…

McKessons (MCK) first-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions…

…

Several publicly traded drug distributors are vying to buy Florida Cancer Specialists & Research Institute, a privately held operator of…

McKessons (MCK) shares have risen 1.5% year to date on the back of solid fundamentals. Increasing volumes of prescription and…

McKessons (MCK) robust Biologics business raises optimism about the stock.…

Paris (www.aktiencheck.de) - McKesson: Erholung in der Abwärtsbewegung - Chartanalyse Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet…

Paris (www.aktiencheck.de) - McKesson-Chartanalyse der BNP Paribas: Rückblick: Die Aktie von McKesson (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet…

…

Investors are optimistic about McKessons (MCK) strength in its Biologics business.…

The availability of the FDA-approved drug via McKessons (MCK) independent specialty pharmacy is expected to give patients improved treatment options…

McKessons (MCK) shares have risen year to date on the back of strong fundamentals. Rising volumes of prescription and specialty…

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.…

Paris (www.aktiencheck.de) - McKesson-Chartanalyse der BNP Paribas: Rückblick: Die McKesson-Aktie (ISIN: US58155Q1031, WKN: 893953, Ticker-Symbol: MCK, NYSE-Symbol: MCK) befindet sich in…

Investors are optimistic about McKessons (MCK) strength in its Biologics business.…

MCK earnings call for the period ending March 31, 2024.…

McKessons (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical…

McKessons (MCK) fourth-quarter fiscal 2024 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions…

…

Cabinet Health is on a mission to reduce single-use plastic from healthcare and they have found like-minded partners in major…

Bernd (Gurupress.de) - Liebe Leser, liebe Leserinnen, hoch, höher, McKesson. Der Techaktien-Masterclass Dauerläufer McKesson hat in der zurückliegenden Handelswoche abermals…

Investors are optimistic about McKessons (MCK) strength in its Biologics business.…

Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson…

Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson…

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.…

McKesson CEO sells over $1.8 million in company stock…

McKesson whistleblowers kickback lawsuit is revived…

MANNHEIM (dpa-AFX) - Der Mannheimer Pharmagroßhändler Phoenix hat Teile von US-Konkurrent McKesson übernommen und stellt sich…